
A Danish-developed test for the detection of testicular cancer through sperm samples is being put to use in Germany, Norway, Sweden and Poland.
Researchers at Rigshospitalet have found a way to identify pre-stage testicular cancer cells in a sperm sample and, backed financially by Højteknologifonden (The High Technology Fund) and working closely with the company Visiopharm, the scientists have automated the process to look for the pre-stage cells in a sperm sample under microscope – work that otherwise requires a lot of manpower.
Allerede abonnent? Log ind.
Læs hele artiklen
Få adgang i 14 dage for 0 kr.
Det kræver intet kreditkort, og du vil ikke overgå til et betalt abonnement efterfølgende.
- Adgang til alle låste artikler
- Modtag vores daglige nyhedsbreve
- Fuld adgang til vores app